| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 | |||||||||||||||||||||||
| (U.S. Dollars in millions, except per share amounts) | ||||||||||||||||||||||||||
Revenue | 2,279 | 2,062 | 6,807 | 6,308 | ||||||||||||||||||||||
| Income from Continuing Operations | 24.1 | 15.1 | 121.1 | 142.7 | ||||||||||||||||||||||
| Net Income | 13.8 | 21.5 | 76.0 | 175.0 | ||||||||||||||||||||||
| Net Income attributable to Dole plc | 5.1 | 14.4 | 54.0 | 164.7 | ||||||||||||||||||||||
| Diluted EPS from Continuing Operations | 0.16 | 0.08 | 1.03 | 1.39 | ||||||||||||||||||||||
| Diluted EPS | 0.05 | 0.15 | 0.56 | 1.73 | ||||||||||||||||||||||
Adjusted EBITDA2 | 80.8 | 82.1 | 322.7 | 317.6 | ||||||||||||||||||||||
Adjusted Net Income2 | 15.0 | 18.0 | 101.3 | 105.6 | ||||||||||||||||||||||
Adjusted Diluted EPS2 | 0.16 | 0.19 | 1.06 | 1.11 | ||||||||||||||||||||||
| Three Months Ended | |||||||||||||||||||||||
September 30, 2025 | September 30, 2024 | ||||||||||||||||||||||
| (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Revenue | Adjusted EBITDA | Revenue | Adjusted EBITDA | ||||||||||||||||||||
| Fresh Fruit | $ | 890,356 | $ | 27,153 | $ | 798,781 | $ | 42,904 | |||||||||||||||
| Diversified Fresh Produce - EMEA | 997,802 | 40,740 | 899,639 | 30,363 | |||||||||||||||||||
| Diversified Fresh Produce - Americas & ROW | 419,991 | 12,876 | 390,057 | 8,805 | |||||||||||||||||||
| Intersegment | (29,234) | — | (26,063) | — | |||||||||||||||||||
| Total | $ | 2,278,915 | $ | 80,769 | $ | 2,062,414 | $ | 82,072 | |||||||||||||||
| Nine Months Ended | |||||||||||||||||||||||
September 30, 2025 | September 30, 2024 | ||||||||||||||||||||||
| (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Revenue | Adjusted EBITDA | Revenue | Adjusted EBITDA | ||||||||||||||||||||
| Fresh Fruit | $ | 2,741,092 | $ | 163,240 | $ | 2,474,461 | $ | 182,958 | |||||||||||||||
| Diversified Fresh Produce - EMEA | 2,990,686 | 117,384 | 2,698,088 | 99,017 | |||||||||||||||||||
| Diversified Fresh Produce - Americas & ROW | 1,169,752 | 42,085 | 1,222,996 | 35,617 | |||||||||||||||||||
| Intersegment | (94,784) | — | (87,666) | — | |||||||||||||||||||
| Total | $ | 6,806,746 | $ | 322,709 | $ | 6,307,879 | $ | 317,592 | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 | ||||||||||||||||||||
| (U.S. Dollars and shares in thousands, except per share amounts) | |||||||||||||||||||||||
| Revenues, net | $ | 2,278,915 | $ | 2,062,414 | $ | 6,806,746 | $ | 6,307,879 | |||||||||||||||
| Cost of sales | (2,123,734) | (1,898,375) | (6,251,072) | (5,748,577) | |||||||||||||||||||
| Gross profit | 155,181 | 164,039 | 555,674 | 559,302 | |||||||||||||||||||
| Selling, marketing, general and administrative expenses | (123,621) | (115,829) | (366,341) | (351,383) | |||||||||||||||||||
| Gain on disposal of businesses | 143 | — | 552 | 75,945 | |||||||||||||||||||
| Gain on asset sales | 842 | 1,573 | 13,966 | 1,901 | |||||||||||||||||||
| Impairment of goodwill | — | — | — | (36,684) | |||||||||||||||||||
| Impairment and asset write-downs of property, plant and equipment and lease assets | (8,394) | (2,049) | (8,576) | (3,326) | |||||||||||||||||||
| Operating income | 24,151 | 47,734 | 195,275 | 245,755 | |||||||||||||||||||
| Other income (expense), net | 12,614 | (4,541) | (6,450) | 9,458 | |||||||||||||||||||
| Interest income | 3,478 | 2,632 | 9,473 | 8,335 | |||||||||||||||||||
| Interest expense | (16,641) | (17,473) | (51,339) | (54,209) | |||||||||||||||||||
| Income from continuing operations before income taxes and equity earnings | 23,602 | 28,352 | 146,959 | 209,339 | |||||||||||||||||||
| Income tax expense | (6,100) | (15,524) | (49,182) | (75,385) | |||||||||||||||||||
| Equity method earnings | 6,559 | 2,303 | 23,352 | 8,711 | |||||||||||||||||||
| Income from continuing operations | 24,061 | 15,131 | 121,129 | 142,665 | |||||||||||||||||||
| (Loss) income from discontinued operations, net of income taxes | (10,236) | 6,384 | (45,156) | 32,351 | |||||||||||||||||||
| Net income | 13,825 | 21,515 | 75,973 | 175,016 | |||||||||||||||||||
| Net income attributable to noncontrolling interests | (8,720) | (7,113) | (21,990) | (10,354) | |||||||||||||||||||
| Net income attributable to Dole plc | $ | 5,105 | $ | 14,402 | $ | 53,983 | $ | 164,662 | |||||||||||||||
| Income (loss) per share - basic: | |||||||||||||||||||||||
| Continuing operations | $ | 0.16 | $ | 0.08 | $ | 1.04 | $ | 1.39 | |||||||||||||||
| Discontinued operations | (0.11) | 0.07 | (0.47) | 0.34 | |||||||||||||||||||
| Net income per share attributable to Dole plc - basic | $ | 0.05 | $ | 0.15 | $ | 0.57 | $ | 1.73 | |||||||||||||||
| Income (loss) per share - diluted: | |||||||||||||||||||||||
| Continuing operations | $ | 0.16 | $ | 0.08 | $ | 1.03 | $ | 1.39 | |||||||||||||||
| Discontinued operations | (0.11) | 0.07 | (0.47) | 0.34 | |||||||||||||||||||
Net income per share attributable to Dole plc - diluted | $ | 0.05 | $ | 0.15 | $ | 0.56 | $ | 1.73 | |||||||||||||||
| Weighted-average shares: | |||||||||||||||||||||||
| Basic | 95,163 | 94,990 | 95,139 | 94,950 | |||||||||||||||||||
| Diluted | 95,979 | 95,614 | 95,835 | 95,395 | |||||||||||||||||||
| Nine Months Ended | |||||||||||
| September 30, 2025 | September 30, 2024 | ||||||||||
| Operating Activities | (U.S. Dollars in thousands) | ||||||||||
| Net income | $ | 75,973 | $ | 175,016 | |||||||
| Loss (income) from discontinued operations, net of taxes | 45,156 | (32,351) | |||||||||
| Income from continuing operations | 121,129 | 142,665 | |||||||||
| Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities - continuing operations: | |||||||||||
| Depreciation and amortization | 83,645 | 72,632 | |||||||||
| Impairment of goodwill | — | 36,684 | |||||||||
| Impairment and asset write-downs of property, plant and equipment | 8,576 | 3,326 | |||||||||
| Net gain on sale of assets | (13,966) | (1,901) | |||||||||
| Net gain on sale of businesses | (552) | (75,945) | |||||||||
| Net loss (gain) on financial instruments | 22,365 | (723) | |||||||||
| Stock-based compensation expense | 5,000 | 6,090 | |||||||||
| Equity method earnings | (23,352) | (8,711) | |||||||||
| Noncash debt refinancing expenses | 1,921 | — | |||||||||
| Amortization of debt discounts and debt issuance costs | 4,733 | 6,255 | |||||||||
| Deferred tax benefit (expense) | 2,075 | (12,353) | |||||||||
| Pension and other postretirement benefit plan expense | 4,535 | 1,982 | |||||||||
| Dividends received from equity method investments | 8,744 | 4,994 | |||||||||
| Gain on insurance proceeds | (11,542) | (527) | |||||||||
| Other | (1,337) | 705 | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Receivables, net of allowances | (203,434) | (89,014) | |||||||||
| Inventories | (5,583) | (9,136) | |||||||||
| Prepaids, other current assets and other assets | (244) | (4,032) | |||||||||
| Accounts payable, accrued liabilities and other liabilities | 24,228 | 33,255 | |||||||||
| Net cash provided by operating activities - continuing operations | 26,941 | 106,245 | |||||||||
| Investing activities | |||||||||||
| Sales of assets | 12,093 | 2,825 | |||||||||
| Capital expenditures | (93,101) | (56,788) | |||||||||
| Proceeds from sale of businesses, net of transaction costs and cash transferred | 68,515 | 117,735 | |||||||||
| Insurance proceeds | 19,550 | 527 | |||||||||
| Purchases of investments | (2) | (262) | |||||||||
| Purchases of unconsolidated affiliates | (2,055) | (504) | |||||||||
| Acquisitions, net of cash acquired | (2,489) | (930) | |||||||||
| Other | (22) | (1,908) | |||||||||
| Net cash provided by investing activities - continuing operations | 2,489 | 60,695 | |||||||||
| Financing activities | |||||||||||
| Proceeds from borrowings and overdrafts | 1,533,582 | 1,273,561 | |||||||||
| Repayments on borrowings and overdrafts and payment of debt refinancing fees | (1,516,208) | (1,425,422) | |||||||||
| Dividends paid to shareholders | (24,171) | (22,899) | |||||||||
| Dividends paid to noncontrolling interests | (22,917) | (23,157) | |||||||||
| Other noncontrolling interest activity, net | — | 78 | |||||||||
| Payment of contingent consideration | (1,015) | (996) | |||||||||
| Net cash used in financing activities - continuing operations | (30,729) | (198,835) | |||||||||
| Effect of foreign exchange rate changes on cash | 17,988 | 1,613 | |||||||||
| Net cash (used in) provided by operating activities - discontinued operations | (27,109) | 23,397 | |||||||||
| Net cash used in investing activities - discontinued operations | (6,626) | (6,139) | |||||||||
| Cash (used in) provided by discontinued operations, net | (33,735) | 17,258 | |||||||||
| Decrease in cash and cash equivalents | (17,046) | (13,023) | |||||||||
| Cash and cash equivalents at beginning of period, including discontinued operations | 331,719 | 277,005 | |||||||||
| Cash and cash equivalents at end of period, including discontinued operations | $ | 314,673 | $ | 263,982 | |||||||
| Supplemental cash flow information: | |||||||||||
| Income tax payments, net of refunds | $ | (71,546) | $ | (62,743) | |||||||
| Interest payments on borrowings | $ | (48,438) | $ | (50,376) | |||||||
September 30, 2025 | December 31, 2024 | ||||||||||
| ASSETS | (U.S. Dollars and shares in thousands) | ||||||||||
| Cash and cash equivalents | $ | 314,673 | $ | 330,017 | |||||||
| Short-term investments | 6,299 | 6,019 | |||||||||
| Trade receivables, net of allowances for credit losses of $21,387 and $19,493, respectively | 584,581 | 473,511 | |||||||||
| Grower advance receivables, net of allowances for credit losses of $34,496 and $29,304, respectively | 166,634 | 104,956 | |||||||||
| Other receivables, net of allowances for credit losses of $14,782 and $15,248, respectively | 154,055 | 125,951 | |||||||||
| Inventories, net of allowances of $4,085 and $4,178, respectively | 448,863 | 430,168 | |||||||||
| Prepaid expenses | 68,330 | 68,918 | |||||||||
| Other current assets | 20,708 | 15,111 | |||||||||
| Fresh Vegetables current assets held for sale | — | 281,990 | |||||||||
| Other assets held for sale | 1,653 | 1,419 | |||||||||
| Total current assets | 1,765,796 | 1,838,060 | |||||||||
| Long-term investments | 14,198 | 14,630 | |||||||||
| Investments in unconsolidated affiliates | 142,712 | 129,322 | |||||||||
| Actively marketed property | 55,887 | 45,778 | |||||||||
| Property, plant and equipment, net of accumulated depreciation of $605,881 and $502,062, respectively | 1,118,915 | 1,120,366 | |||||||||
| Operating lease right-of-use assets | 352,708 | 341,722 | |||||||||
| Goodwill | 449,180 | 429,590 | |||||||||
| DOLE brand | 306,280 | 306,280 | |||||||||
| Other intangible assets, net of accumulated amortization of $132,626 and $118,956, respectively | 20,502 | 25,238 | |||||||||
| Other assets | 140,962 | 112,893 | |||||||||
| Deferred tax assets, net | 85,695 | 82,484 | |||||||||
| Total assets | $ | 4,452,835 | $ | 4,446,363 | |||||||
| LIABILITIES AND EQUITY | |||||||||||
| Accounts payable | $ | 706,669 | $ | 648,591 | |||||||
| Income taxes payable | 36,516 | 42,753 | |||||||||
| Accrued liabilities | 489,299 | 443,145 | |||||||||
| Bank overdrafts | 14,706 | 11,443 | |||||||||
| Current portion of long-term debt, net | 57,445 | 80,097 | |||||||||
| Current maturities of operating leases | 68,192 | 64,357 | |||||||||
| Payroll and other tax | 26,348 | 28,056 | |||||||||
| Contingent consideration | 4,652 | 3,399 | |||||||||
| Pension and other postretirement benefits | 18,114 | 18,491 | |||||||||
| Fresh Vegetables current liabilities held for sale | — | 214,387 | |||||||||
| Dividends payable and other current liabilities | 38,428 | 14,696 | |||||||||
| Total current liabilities | 1,460,369 | 1,569,415 | |||||||||
| Long-term debt, net | 899,299 | 866,075 | |||||||||
| Operating leases, less current maturities | 290,290 | 280,896 | |||||||||
| Deferred tax liabilities, net | 76,720 | 84,712 | |||||||||
| Income taxes payable, less current portion | — | 6,210 | |||||||||
| Contingent consideration, less current portion | 1,202 | 4,007 | |||||||||
| Pension and other postretirement benefits, less current portion | 129,617 | 129,870 | |||||||||
| Other long-term liabilities | 75,479 | 70,260 | |||||||||
| Total liabilities | $ | 2,932,976 | $ | 3,011,445 | |||||||
| Redeemable noncontrolling interests | 32,568 | 35,554 | |||||||||
| Stockholders’ equity: | |||||||||||
| Common stock — $0.01 par value; 300,000 shares authorized; 95,163 and 95,041 shares outstanding as of September 30, 2025 and December 31, 2024, respectively | 952 | 950 | |||||||||
| Additional paid-in capital | 800,225 | 801,099 | |||||||||
| Retained earnings | 687,242 | 657,430 | |||||||||
| Accumulated other comprehensive loss | (108,529) | (166,180) | |||||||||
| Total equity attributable to Dole plc | 1,379,890 | 1,293,299 | |||||||||
| Equity attributable to noncontrolling interests | 107,401 | 106,065 | |||||||||
| Total equity | 1,487,291 | 1,399,364 | |||||||||
| Total liabilities, redeemable noncontrolling interests and equity | $ | 4,452,835 | $ | 4,446,363 | |||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 | ||||||||||||||||||||
| (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Net income (Reported GAAP) | $ | 13,825 | $ | 21,515 | $ | 75,973 | $ | 175,016 | |||||||||||||||
| Loss (income) from discontinued operations, net of income taxes | 10,236 | (6,384) | 45,156 | (32,351) | |||||||||||||||||||
| Income from continuing operations (Reported GAAP) | 24,061 | 15,131 | 121,129 | 142,665 | |||||||||||||||||||
| Income tax expense | 6,100 | 15,524 | 49,182 | 75,385 | |||||||||||||||||||
| Interest expense | 16,641 | 17,473 | 51,339 | 54,209 | |||||||||||||||||||
| Mark to market (gains) losses | (1,000) | 6,301 | 22,069 | 1,217 | |||||||||||||||||||
| Gain on asset sales | — | (66) | (11,178) | (35) | |||||||||||||||||||
| Gain on disposal of businesses | (143) | — | (552) | (75,945) | |||||||||||||||||||
| Impairment of goodwill | — | — | — | 36,684 | |||||||||||||||||||
| Asset write-downs, net of insurance proceeds | (8,257) | (992) | (11,874) | (2,691) | |||||||||||||||||||
| Impairment of property, plant and equipment and lease assets | 8,208 | — | 8,208 | — | |||||||||||||||||||
| Other items4,5 | 795 | 9 | 4,078 | (18) | |||||||||||||||||||
| Adjustments from equity method investments | 3,280 | 2,504 | 629 | 6,964 | |||||||||||||||||||
| Adjusted EBIT (Non-GAAP) | 49,685 | 55,884 | 233,030 | 238,435 | |||||||||||||||||||
| Depreciation | 27,022 | 22,616 | 78,331 | 66,852 | |||||||||||||||||||
| Amortization of intangible assets | 1,845 | 1,621 | 5,314 | 5,780 | |||||||||||||||||||
| Depreciation and amortization adjustments from equity method investments | 2,217 | 1,951 | 6,034 | 6,525 | |||||||||||||||||||
| Adjusted EBITDA (Non-GAAP) | $ | 80,769 | $ | 82,072 | $ | 322,709 | $ | 317,592 | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 | ||||||||||||||||||||
| (U.S. Dollars and shares in thousands, except per share amounts) | |||||||||||||||||||||||
| Net income attributable to Dole plc (Reported GAAP) | $ | 5,105 | $ | 14,402 | $ | 53,983 | $ | 164,662 | |||||||||||||||
| Loss (income) from discontinued operations, net of income taxes | 10,236 | (6,384) | 45,156 | (32,351) | |||||||||||||||||||
| Income from continuing operations attributable to Dole plc | 15,341 | 8,018 | 99,139 | 132,311 | |||||||||||||||||||
| Adjustments: | |||||||||||||||||||||||
| Amortization of intangible assets | 1,845 | 1,621 | 5,314 | 5,780 | |||||||||||||||||||
| Mark to market (gains) losses | (1,000) | 6,301 | 22,069 | 1,217 | |||||||||||||||||||
| Gain on asset sales | — | (66) | (11,178) | (35) | |||||||||||||||||||
| Gain on disposal of businesses | (143) | — | (552) | (75,945) | |||||||||||||||||||
| Impairment of goodwill | — | — | — | 36,684 | |||||||||||||||||||
| Asset write-downs, net of insurance proceeds | (8,257) | (992) | (11,874) | (2,691) | |||||||||||||||||||
| Impairment of property, plant and equipment and lease assets | 8,208 | — | 8,208 | — | |||||||||||||||||||
| Other items6,7 | 795 | 9 | 4,078 | (18) | |||||||||||||||||||
| Adjustments from equity method investments | 272 | 531 | (7,160) | 1,782 | |||||||||||||||||||
| Income tax on items above and discrete tax items | (2,361) | 3,393 | (4,492) | 18,500 | |||||||||||||||||||
| NCI impact of items above | 318 | (781) | (2,302) | (11,968) | |||||||||||||||||||
| Adjusted Net Income for Adjusted EPS calculation (Non-GAAP) | $ | 15,018 | $ | 18,034 | $ | 101,250 | $ | 105,617 | |||||||||||||||
| Adjusted earnings per share – basic (Non-GAAP) | $ | 0.16 | $ | 0.19 | $ | 1.06 | $ | 1.11 | |||||||||||||||
| Adjusted earnings per share – diluted (Non-GAAP) | $ | 0.16 | $ | 0.19 | $ | 1.06 | $ | 1.11 | |||||||||||||||
| Weighted average shares outstanding – basic | 95,163 | 94,990 | 95,139 | 94,950 | |||||||||||||||||||
| Weighted average shares outstanding – diluted | 95,979 | 95,614 | 95,835 | 95,395 | |||||||||||||||||||
Three Months Ended September 30, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Revenues, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administrative expenses | Other operating items8 | Operating Income | |||||||||||||||||
| Reported (GAAP) | $ | 2,278,915 | (2,123,734) | 155,181 | 6.8 | % | (123,621) | (7,409) | $ | 24,151 | |||||||||||||
| Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
| Amortization of intangible assets | — | — | — | 1,845 | — | 1,845 | |||||||||||||||||
| Mark to market (gains) losses | — | (381) | (381) | — | — | (381) | |||||||||||||||||
| Gain on asset sales | — | — | — | — | — | — | |||||||||||||||||
| Gain on disposal of businesses | — | — | — | — | (143) | (143) | |||||||||||||||||
| Asset write-downs, net of insurance proceeds | — | 1,731 | 1,731 | — | — | 1,731 | |||||||||||||||||
| Impairment of property, plant and equipment and lease assets | — | — | — | — | 8,208 | 8,208 | |||||||||||||||||
| Other items | — | — | — | 795 | — | 795 | |||||||||||||||||
| Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
| Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
| NCI impact of items above | — | — | — | — | — | — | |||||||||||||||||
| Adjusted (Non-GAAP) | $ | 2,278,915 | (2,122,384) | 156,531 | 6.9 | % | (120,981) | 656 | $ | 36,206 | |||||||||||||
Three Months Ended September 30, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Revenues, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administrative expenses | Other operating items9 | Operating Income | |||||||||||||||||
| Reported (GAAP) | $ | 2,062,414 | (1,898,375) | 164,039 | 8.0 | % | (115,829) | (476) | $ | 47,734 | |||||||||||||
| Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
| Amortization of intangible assets | — | — | — | 1,621 | — | 1,621 | |||||||||||||||||
| Mark to market (gains) losses | — | 270 | 270 | — | — | 270 | |||||||||||||||||
| Gain on asset sales | — | — | — | — | (66) | (66) | |||||||||||||||||
| Gain on disposal of businesses | — | — | — | — | — | — | |||||||||||||||||
| Impairment of goodwill | — | — | — | — | — | — | |||||||||||||||||
| Asset write-downs, net of insurance proceeds | — | (992) | (992) | — | — | (992) | |||||||||||||||||
| Other items | — | 6 | 6 | — | — | 6 | |||||||||||||||||
| Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
| Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
| NCI impact of items above | — | — | — | — | — | — | |||||||||||||||||
| Adjusted (Non-GAAP) | $ | 2,062,414 | (1,899,091) | 163,323 | 7.9 | % | (114,208) | (542) | $ | 48,573 | |||||||||||||
Three Months Ended September 30, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Other (expense) income, net | Interest income | Interest expense | Income tax expense | Equity method earnings | Income from continuing operations | (Loss) income from discontinued operations, net of income taxes | |||||||||||||||||
| Reported (GAAP) | $ | 12,614 | 3,478 | (16,641) | (6,100) | 6,559 | 24,061 | (10,236) | |||||||||||||||
| Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | 10,236 | ||||||||||||||||
| Amortization of intangible assets | — | — | — | — | — | 1,845 | — | ||||||||||||||||
| Mark to market (gains) losses | (619) | — | — | — | — | (1,000) | — | ||||||||||||||||
| Gain on asset sales | — | — | — | — | — | — | — | ||||||||||||||||
| Gain on disposal of businesses | — | — | — | — | — | (143) | — | ||||||||||||||||
| Asset write-downs, net of insurance proceeds | (9,988) | — | — | — | — | (8,257) | — | ||||||||||||||||
| Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 8,208 | — | ||||||||||||||||
| Other items | — | — | — | — | — | 795 | — | ||||||||||||||||
| Adjustments from equity method investments | — | — | — | — | 272 | 272 | — | ||||||||||||||||
| Income tax on items above and discrete tax items | — | — | — | (2,310) | (51) | (2,361) | — | ||||||||||||||||
| NCI impact of items above | — | — | — | — | — | — | — | ||||||||||||||||
| Adjusted (Non-GAAP) | $ | 2,007 | 3,478 | (16,641) | (8,410) | 6,780 | 23,420 | $ | — | ||||||||||||||
Three Months Ended September 30, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Other (expense) income, net | Interest income | Interest expense | Income tax expense | Equity method earnings | Income from continuing operations | (Loss) income from discontinued operations, net of income taxes | |||||||||||||||||
| Reported (GAAP) | $ | (4,541) | 2,632 | (17,473) | (15,524) | 2,303 | 15,131 | 6,384 | |||||||||||||||
| Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | (6,384) | ||||||||||||||||
| Amortization of intangible assets | — | — | — | — | — | 1,621 | — | ||||||||||||||||
| Mark to market (gains) losses | 6,031 | — | — | — | — | 6,301 | — | ||||||||||||||||
| Gain on asset sales | — | — | — | — | — | (66) | — | ||||||||||||||||
| Gain on disposal of businesses | — | — | — | — | — | — | — | ||||||||||||||||
| Impairment of goodwill | — | — | — | — | — | — | — | ||||||||||||||||
| Asset write-downs, net of insurance proceeds | — | — | — | — | — | (992) | — | ||||||||||||||||
| Other items | 3 | — | — | — | — | 9 | — | ||||||||||||||||
| Adjustments from equity method investments | — | — | — | — | 531 | 531 | — | ||||||||||||||||
| Income tax on items above and discrete tax items | — | — | — | 3,493 | (100) | 3,393 | — | ||||||||||||||||
| NCI impact of items above | — | — | — | — | — | — | — | ||||||||||||||||
| Adjusted (Non-GAAP) | $ | 1,493 | 2,632 | (17,473) | (12,031) | 2,734 | 25,928 | $ | — | ||||||||||||||
Three Months Ended September 30, 2025 U.S. Dollars and shares in thousands, except per share amounts | ||||||||||||||
| Net income | Net income attributable to noncontrolling interests | Net income attributable to Dole plc | Diluted net income per share | |||||||||||
| Reported (GAAP) | $ | 13,825 | $ | (8,720) | $ | 5,105 | $ | 0.05 | ||||||
| Loss (income) from discontinued operations, net of income taxes | 10,236 | — | 10,236 | |||||||||||
| Amortization of intangible assets | 1,845 | — | 1,845 | |||||||||||
| Mark to market (gains) losses | (1,000) | — | (1,000) | |||||||||||
| Gain on asset sales | — | — | — | |||||||||||
| Gain on disposal of businesses | (143) | — | (143) | |||||||||||
| Asset write-downs, net of insurance proceeds | (8,257) | — | (8,257) | |||||||||||
| Impairment of property, plant and equipment and lease assets | 8,208 | — | 8,208 | |||||||||||
| Other items | 795 | — | 795 | |||||||||||
| Adjustments from equity method investments | 272 | — | 272 | |||||||||||
| Income tax on items above and discrete tax items | (2,361) | — | (2,361) | |||||||||||
| NCI impact of items above | — | 318 | 318 | |||||||||||
| Adjusted (Non-GAAP) | $ | 23,420 | $ | (8,402) | $ | 15,018 | $ | 0.16 | ||||||
| Weighted average shares outstanding – diluted | 95,979 | |||||||||||||
Three Months Ended September 30, 2024 U.S. Dollars and shares in thousands, except per share amounts | ||||||||||||||
| Net income | Net income attributable to noncontrolling interests | Net income attributable to Dole plc | Diluted net income per share | |||||||||||
| Reported (GAAP) | $ | 21,515 | $ | (7,113) | $ | 14,402 | $ | 0.15 | ||||||
| Loss (income) from discontinued operations, net of income taxes | (6,384) | — | (6,384) | |||||||||||
| Amortization of intangible assets | 1,621 | — | 1,621 | |||||||||||
| Mark to market (gains) losses | 6,301 | — | 6,301 | |||||||||||
| Gain on asset sales | (66) | — | (66) | |||||||||||
| Gain on disposal of businesses | — | — | — | |||||||||||
| Impairment of goodwill | — | — | — | |||||||||||
| Asset write-downs, net of insurance proceeds | (992) | — | (992) | |||||||||||
| Other items | 9 | — | 9 | |||||||||||
| Adjustments from equity method investments | 531 | — | 531 | |||||||||||
| Income tax on items above and discrete tax items | 3,393 | — | 3,393 | |||||||||||
| NCI impact of items above | — | (781) | (781) | |||||||||||
| Adjusted (Non-GAAP) | $ | 25,928 | $ | (7,894) | $ | 18,034 | $ | 0.19 | ||||||
| Weighted average shares outstanding – diluted | 95,614 | |||||||||||||
Nine Months Ended September 30, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Revenues, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administrative expenses | Other operating items10 | Operating Income | |||||||||||||||||
| Reported (GAAP) | $ | 6,806,746 | (6,251,072) | 555,674 | 8.2 | % | (366,341) | 5,942 | $ | 195,275 | |||||||||||||
| Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
| Amortization of intangible assets | — | — | — | 5,314 | — | 5,314 | |||||||||||||||||
| Mark to market (gains) losses | — | 1,876 | 1,876 | — | — | 1,876 | |||||||||||||||||
| Gain on asset sales | — | — | — | — | (11,178) | (11,178) | |||||||||||||||||
| Gain on disposal of businesses | — | — | — | — | (552) | (552) | |||||||||||||||||
| Asset write-downs, net of insurance proceeds | — | (1,886) | (1,886) | — | — | (1,886) | |||||||||||||||||
| Impairment of property, plant and equipment and lease assets | — | — | — | — | 8,208 | 8,208 | |||||||||||||||||
| Other items | — | — | — | 896 | — | 896 | |||||||||||||||||
| Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
| Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
| NCI impact of items above | — | — | — | — | — | — | |||||||||||||||||
| Adjusted (Non-GAAP) | $ | 6,806,746 | (6,251,082) | 555,664 | 8.2 | % | (360,131) | 2,420 | $ | 197,953 | |||||||||||||
Nine Months Ended September 30, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Revenues, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administrative expenses | Other operating items11 | Operating Income | |||||||||||||||||
| Reported (GAAP) | $ | 6,307,879 | (5,748,577) | 559,302 | 8.9 | % | (351,383) | 37,836 | $ | 245,755 | |||||||||||||
| Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
| Amortization of intangible assets | — | — | — | 5,780 | — | 5,780 | |||||||||||||||||
| Mark to market (gains) losses | — | 150 | 150 | — | — | 150 | |||||||||||||||||
| Gain on asset sales | — | — | — | — | (35) | (35) | |||||||||||||||||
| Gain on disposal of businesses | — | — | — | — | (75,945) | (75,945) | |||||||||||||||||
| Impairment of goodwill | — | — | — | — | 36,684 | 36,684 | |||||||||||||||||
| Asset write-downs, net of insurance proceeds | — | (2,691) | (2,691) | — | — | (2,691) | |||||||||||||||||
| Other items | — | 62 | 62 | — | — | 62 | |||||||||||||||||
| Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
| Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
| NCI impact of items above | — | — | — | — | — | — | |||||||||||||||||
| Adjusted (Non-GAAP) | $ | 6,307,879 | (5,751,056) | 556,823 | 8.8 | % | (345,603) | (1,460) | $ | 209,760 | |||||||||||||
Nine Months Ended September 30, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Other (expense) income, net | Interest income | Interest expense | Income tax expense | Equity method earnings | Income from continuing operations | (Loss) income from discontinued operations, net of income taxes | |||||||||||||||||
| Reported (GAAP) | $ | (6,450) | 9,473 | (51,339) | (49,182) | 23,352 | 121,129 | (45,156) | |||||||||||||||
| Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | 45,156 | ||||||||||||||||
| Amortization of intangible assets | — | — | — | — | — | 5,314 | — | ||||||||||||||||
| Mark to market (gains) losses | 20,193 | — | — | — | — | 22,069 | — | ||||||||||||||||
| Gain on asset sales | — | — | — | — | — | (11,178) | — | ||||||||||||||||
| Gain on disposal of businesses | — | — | — | — | — | (552) | — | ||||||||||||||||
| Asset write-downs, net of insurance proceeds | (9,988) | — | — | — | — | (11,874) | — | ||||||||||||||||
| Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 8,208 | — | ||||||||||||||||
| Other items | 3,182 | — | — | — | — | 4,078 | — | ||||||||||||||||
| Adjustments from equity method investments | — | — | — | — | (7,160) | (7,160) | — | ||||||||||||||||
| Income tax on items above and discrete tax items | — | — | — | (5,128) | 636 | (4,492) | — | ||||||||||||||||
| NCI impact of items above | — | — | — | — | — | — | — | ||||||||||||||||
| Adjusted (Non-GAAP) | $ | 6,937 | 9,473 | (51,339) | (54,310) | 16,828 | 125,542 | $ | — | ||||||||||||||
Nine Months Ended September 30, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
| Other (expense) income, net | Interest income | Interest expense | Income tax expense | Equity method earnings | Income from continuing operations | (Loss) income from discontinued operations, net of income taxes | |||||||||||||||||
| Reported (GAAP) | $ | 9,458 | 8,335 | (54,209) | (75,385) | 8,711 | 142,665 | 32,351 | |||||||||||||||
| Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | (32,351) | ||||||||||||||||
| Amortization of intangible assets | — | — | — | — | — | 5,780 | — | ||||||||||||||||
| Mark to market (gains) losses | 1,067 | — | — | — | — | 1,217 | — | ||||||||||||||||
| Gain on asset sales | — | — | — | — | — | (35) | — | ||||||||||||||||
| Gain on disposal of businesses | — | — | — | — | — | (75,945) | — | ||||||||||||||||
| Impairment of goodwill | — | — | — | — | — | 36,684 | — | ||||||||||||||||
| Asset write-downs, net of insurance proceeds | — | — | — | — | — | (2,691) | — | ||||||||||||||||
| Other items | (80) | — | — | — | — | (18) | — | ||||||||||||||||
| Adjustments from equity method investments | — | — | — | — | 1,782 | 1,782 | — | ||||||||||||||||
| Income tax on items above and discrete tax items | — | — | — | 18,800 | (300) | 18,500 | — | ||||||||||||||||
| NCI impact of items above | — | — | — | — | — | — | — | ||||||||||||||||
| Adjusted (Non-GAAP) | $ | 10,445 | 8,335 | (54,209) | (56,585) | 10,193 | 127,939 | $ | — | ||||||||||||||
Nine Months Ended September 30, 2025 U.S. Dollars and shares in thousands, except per share amounts | ||||||||||||||
| Net income | Net income attributable to noncontrolling interests | Net income attributable to Dole plc | Diluted net income per share | |||||||||||
| Reported (GAAP) | $ | 75,973 | $ | (21,990) | $ | 53,983 | $ | 0.56 | ||||||
| Loss (income) from discontinued operations, net of income taxes | 45,156 | — | 45,156 | |||||||||||
| Amortization of intangible assets | 5,314 | — | 5,314 | |||||||||||
| Mark to market (gains) losses | 22,069 | — | 22,069 | |||||||||||
| Gain on asset sales | (11,178) | — | (11,178) | |||||||||||
| Gain on disposal of businesses | (552) | — | (552) | |||||||||||
| Asset write-downs, net of insurance proceeds | (11,874) | — | (11,874) | |||||||||||
| Impairment of property, plant and equipment and lease assets | 8,208 | — | 8,208 | |||||||||||
| Other items | 4,078 | — | 4,078 | |||||||||||
| Adjustments from equity method investments | (7,160) | — | (7,160) | |||||||||||
| Income tax on items above and discrete tax items | (4,492) | — | (4,492) | |||||||||||
| NCI impact of items above | — | (2,302) | (2,302) | |||||||||||
| Adjusted (Non-GAAP) | $ | 125,542 | $ | (24,292) | $ | 101,250 | $ | 1.06 | ||||||
| Weighted average shares outstanding – diluted | 95,835 | |||||||||||||
Nine Months Ended September 30, 2024 U.S. Dollars and shares in thousands, except per share amounts | ||||||||||||||
| Net income | Net income attributable to noncontrolling interests | Net income attributable to Dole plc | Diluted net income per share | |||||||||||
| Reported (GAAP) | $ | 175,016 | $ | (10,354) | $ | 164,662 | $ | 1.73 | ||||||
| Loss (income) from discontinued operations, net of income taxes | (32,351) | — | (32,351) | |||||||||||
| Amortization of intangible assets | 5,780 | — | 5,780 | |||||||||||
| Mark to market (gains) losses | 1,217 | — | 1,217 | |||||||||||
| Gain on asset sales | (35) | — | (35) | |||||||||||
| Gain on disposal of businesses | (75,945) | — | (75,945) | |||||||||||
| Impairment of goodwill | 36,684 | — | 36,684 | |||||||||||
| Asset write-downs, net of insurance proceeds | (2,691) | — | (2,691) | |||||||||||
| Other items | (18) | — | (18) | |||||||||||
| Adjustments from equity method investments | 1,782 | — | 1,782 | |||||||||||
| Income tax on items above and discrete tax items | 18,500 | — | 18,500 | |||||||||||
| NCI impact of items above | — | (11,968) | (11,968) | |||||||||||
| Adjusted (Non-GAAP) | $ | 127,939 | $ | (22,322) | $ | 105,617 | $ | 1.11 | ||||||
| Weighted average shares outstanding – diluted | 95,395 | |||||||||||||
Revenue for the Three Months Ended | |||||||||||||||||||||||||||||
| September 30, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | September 30, 2025 | |||||||||||||||||||||||||
| (U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
| Fresh Fruit | $ | 798,781 | $ | 226 | $ | — | $ | 91,349 | $ | 890,356 | |||||||||||||||||||
| Diversified Fresh Produce - EMEA | 899,639 | 56,753 | (8,617) | 50,027 | 997,802 | ||||||||||||||||||||||||
| Diversified Fresh Produce - Americas & ROW | 390,057 | (917) | — | 30,851 | 419,991 | ||||||||||||||||||||||||
| Intersegment | (26,063) | — | — | (3,171) | (29,234) | ||||||||||||||||||||||||
| Total | $ | 2,062,414 | $ | 56,062 | $ | (8,617) | $ | 169,056 | $ | 2,278,915 | |||||||||||||||||||
Adjusted EBITDA for the Three Months Ended | |||||||||||||||||||||||||||||
| September 30, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | September 30, 2025 | |||||||||||||||||||||||||
| (U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
| Fresh Fruit | $ | 42,904 | $ | (267) | $ | 177 | $ | (15,661) | $ | 27,153 | |||||||||||||||||||
| Diversified Fresh Produce - EMEA | 30,363 | 2,827 | 132 | 7,418 | 40,740 | ||||||||||||||||||||||||
| Diversified Fresh Produce - Americas & ROW | 8,805 | (119) | 144 | 4,046 | 12,876 | ||||||||||||||||||||||||
| Total | $ | 82,072 | $ | 2,441 | $ | 453 | $ | (4,197) | $ | 80,769 | |||||||||||||||||||
Revenue for the Nine Months Ended | |||||||||||||||||||||||||||||
| September 30, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | September 30, 2025 | |||||||||||||||||||||||||
| (U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
| Fresh Fruit | $ | 2,474,461 | $ | 537 | $ | — | $ | 266,094 | $ | 2,741,092 | |||||||||||||||||||
| Diversified Fresh Produce - EMEA | 2,698,088 | 95,014 | (28,663) | 226,247 | 2,990,686 | ||||||||||||||||||||||||
| Diversified Fresh Produce - Americas & ROW | 1,222,996 | (3,330) | (79,307) | 29,393 | 1,169,752 | ||||||||||||||||||||||||
| Intersegment | (87,666) | — | — | (7,118) | (94,784) | ||||||||||||||||||||||||
| Total | $ | 6,307,879 | $ | 92,221 | $ | (107,970) | $ | 514,616 | $ | 6,806,746 | |||||||||||||||||||
Adjusted EBITDA for the Nine Months Ended | |||||||||||||||||||||||||||||
| September 30, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | September 30, 2025 | |||||||||||||||||||||||||
| (U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
| Fresh Fruit | $ | 182,958 | $ | (362) | $ | 387 | $ | (19,743) | $ | 163,240 | |||||||||||||||||||
| Diversified Fresh Produce - EMEA | 99,017 | 4,626 | 138 | 13,603 | 117,384 | ||||||||||||||||||||||||
| Diversified Fresh Produce - Americas & ROW | 35,617 | (351) | (1,974) | 8,793 | 42,085 | ||||||||||||||||||||||||
| Total | $ | 317,592 | $ | 3,913 | $ | (1,449) | $ | 2,653 | $ | 322,709 | |||||||||||||||||||
September 30, 2025 | December 31, 2024 | ||||||||||
(U.S. Dollars in thousands) | |||||||||||
| Cash and cash equivalents (Reported GAAP) | $ | 314,673 | $ | 330,017 | |||||||
| Debt (Reported GAAP): | |||||||||||
| Long-term debt, net | (899,299) | (866,075) | |||||||||
| Current maturities | (57,445) | (80,097) | |||||||||
| Bank overdrafts | (14,706) | (11,443) | |||||||||
| Total debt, net | (971,450) | (957,615) | |||||||||
| Add: Debt discounts and debt issuance costs (Reported GAAP) | (7,692) | (9,531) | |||||||||
| Total gross debt | (979,142) | (967,146) | |||||||||
Net Debt (Non-GAAP) | $ | (664,469) | $ | (637,129) | |||||||
| LTM Adjusted EBITDA (Non-GAAP) | 397,320 | 392,203 | |||||||||
| Net Leverage (Non-GAAP) | 1.7x | 1.6x | |||||||||
| Last Twelve Months ("LTM") Adjusted EBITDA | |||||||||||
| FY'24 Adjusted EBITDA | 392,203 | 392,203 | |||||||||
| Less: Q3'24 YTD Adjusted EBITDA | (317,592) | ||||||||||
| Plus: Q3'25 YTD Adjusted EBITDA | 322,709 | ||||||||||
| LTM Adjusted EBITDA | $ | 397,320 | $ | 392,203 | |||||||
Nine Months Ended | |||||||||||
| September 30, 2025 | September 30, 2024 | ||||||||||
(U.S. Dollars in thousands) | |||||||||||
| Net cash provided by operating activities - continuing operations (Reported GAAP) | $ | 26,941 | $ | 106,245 | |||||||
| Less: Capital expenditures (Reported GAAP)12 | (93,101) | (56,788) | |||||||||
Free cash flow from continuing operations (Non-GAAP) | $ | (66,160) | $ | 49,457 | |||||||